June is Cancer Immunotherapy Month. Definiens transforms insights into impactful immunotherapies. To learn more, contact us today: hubs.ly/H0cF0sj0 #CIM18

FDA chief moves to promote artificial intelligence in health care thehill.com/policy/healthc…

Automated tissue image analysis can reveal powerful insights that guide the development of effective and personalized #immunotherapies. Register for the #webinar on deep-learning-based scoring of PD-L1 expression in #NSCLC. hubs.ly/H0cZrQ60

Register for #webinar by Dr. Nicolas Brieu about automating PD-L1 scoring using deep learning to identify PD-L1 status in tumor cell regions in resected #NSCLC. hubs.ly/H0cZqpd0

Register for #webinar by Dr. Nicolas Brieu about automating PD-L1 scoring using deep learning to identify PD-L1 status in #tumor cell regions of resected #NSCLC. hubs.ly/H0cZry-0

#Webinar: Automated PD-L1 tumor cell scoring in resected #NSCLC using novel deep learning approach. #immunotherapy hubs.ly/H0cZrVx0

Definiens strengthens digital data and science strategy with new COO #TissuePhenomics hubs.ly/H0d7kfN0

Going to #ESMO18? Join Definiens in Munich on October 18, 2018, to learn how our team of experts help biopharma companies discover and derive impactful insights from their tissue slides. hubs.ly/H0drP0z0 #Immunoprofiling #immuno-oncology

We are excited to announce our upcoming #webinar on Sept. 12 featuring our own Dr. Florian Leiß and Dr. Moritz Widmaier, “Tissue-based profiling for confident decisions in immuno-oncology.” Register today: hubs.ly/H0dtK7w0 #TissuePhenomics #immunooncology

How can drug development and trial designs in immuno-oncology benefit from standardized tissue profiling? Join us on Sept. 12 for our upcoming #webinar to find out. Register here: hubs.ly/H0dtLxP0 #TissuePhenomics #immunooncology

We are excited to announce our new partnership with Merck KGaA! Check out our latest press release to learn more: hubs.ly/H0dHzL10 #tissuephenomics #immunoprofiling

Don’t forget, our webinar “Tissue-based profiling for confident decisions in immuno-oncology” is this Wednesday, Sept. 12! Register here to reserve your spot: hubs.ly/H0dtMFZ0 #TissuePhenomics #immunooncology

#Webinar-->Tissue-based profiling for confident decisions in immuno-oncology. Watch now. hubs.ly/H0dQhVV0

We’ve developed an automated workflow for quantitative analysis of multispectral immunofluorescence whole-tissue scans. Learn more at our Oct. 9 webinar: hubs.ly/H0dw_Jb0 #immunooncology

Looking forward to #SITC2018 in Washington DC today! Stop by Booth #310 this week to learn how Definiens can help you unlock a greater understanding of the tumor microenvironment. #immunoOncology #DefiniensSITC2018 hubs.ly/H0frkNm0

Definiens to showcase 5 successful immuno-oncology studies at SITC 2018 prn.to/2PgfvGJ

Be sure to read our research paper by Definiens' Ansh Kapil & Nicolas Brieu and the team on Scientific Reports "Deep Semi Supervised Generative Learning for Automated Tumor Proportion Scoring on NSCLC Tissue Needle Biopsies" #immunoOncology hubs.ly/H0fHQgm0

Don't miss our next free #INSPIRESERIES2019 event in Boston/Cambridge! We'll have Dr. Nicolas Brieu present 'Machine and #DeepLearning for the Analysis of Multiplexed IF Images. Snacks and drinks included - save your spot now! #immunooncology hubs.ly/H0hlt0d0

The Definiens Tissue Phenomics® Difference - Standardized Services - IO-Panel, this standardized immune-oncology solution includes 7 key biomarkers for faster turn-around time, and consistent, repeatable results. Learn More at #AACR18 Booth 1423.